Literature DB >> 7507973

The interleukin-4 receptor: signal transduction by a hematopoietin receptor.

A D Keegan1, J H Pierce.   

Abstract

Over the last several years, the receptors for numerous cytokines have been molecularly characterized. Analysis of their amino acid sequences shows that some of these receptors bear certain motifs in their extracellular domains that define a family of receptors called the Hematopoietin receptor superfamily. Significant advances in characterizing the structure, function, and mechanisms of signal transduction have been made for several members of this family. The purpose of this review is to discuss the recent advances made for one of the family members, the interleukin (IL) 4 receptor. Other receptor systems have recently been reviewed elsewhere. The IL-4 receptor consists of, at the minimum, the cloned 140 kDa IL-4-binding chain with the potential for associating with other chains. The IL-4 receptor transduces its signal by activating a tyrosine kinase that phosphorylates cellular substrates, including the receptor itself, and the 170 kDa substrate called 4PS. Phosphorylated 4PS interacts with the SH2 domain of the enzyme PI-3'-kinase and increases its enzymatic activity. These early events in the IL-4 receptor initiated signaling pathway may trigger a series of signals that will ultimately lead to an IL-4 specific biologic outcome.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7507973     DOI: 10.1002/jlb.55.2.272

Source DB:  PubMed          Journal:  J Leukoc Biol        ISSN: 0741-5400            Impact factor:   4.962


  5 in total

1.  Growth inhibition signalled through the interleukin-4/interleukin-13 receptor complex is associated with tyrosine phosphorylation of insulin receptor substrate-1.

Authors:  B Schnyder; H Lahm; G Woerly; N Odartchenko; B Ryffel; B D Car
Journal:  Biochem J       Date:  1996-05-01       Impact factor: 3.857

2.  Treatment in vitro of retinal cells with IL-4 increases the survival of retinal ganglion cells: the involvement of BDNF.

Authors:  Leandro de Araujo-Martins; Raphael Monteiro de Oliveira; Gabriela Velozo Gomes dos Santos; Renata Cláudia Celestino dos Santos; Aline Araujo dos Santos; Elizabeth Giestal de Araujo
Journal:  Neurochem Res       Date:  2012-10-16       Impact factor: 3.996

3.  Modulation of cell-bound and soluble CD23, spontaneous and ongoing IgE synthesis of human peripheral blood mononuclear cells by soluble IL-4 receptors and the partial antagonistic IL-4 mutant protein IL-4 (Y124D).

Authors:  B König; A Fischer; W König
Journal:  Immunology       Date:  1995-08       Impact factor: 7.397

4.  Direct evidence of a heterotrimeric complex of human interleukin-4 with its receptors.

Authors:  R C Hoffman; B J Castner; M Gerhart; M G Gibson; B D Rasmussen; C J March; J Weatherbee; M Tsang; A Gustchina; C Schalk-Hihi
Journal:  Protein Sci       Date:  1995-03       Impact factor: 6.725

5.  Bladder carcinomas and normal urothelium universally express gp200-MR6, a molecule functionally associated with the interleukin 4 receptor (CD 124).

Authors:  M F Tungekar; K C Gatter; M A Ritter
Journal:  Br J Cancer       Date:  1996-02       Impact factor: 7.640

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.